Neuroone Medical Technologies (NMTC) Long-Term Deferred Tax (2018 - 2025)

Neuroone Medical Technologies (NMTC) has 8 years of Long-Term Deferred Tax data on file, last reported at $20.6 million in Q3 2025.

• For the quarter ending Q3 2025, Long-Term Deferred Tax rose 7.32% year-over-year to $20.6 million; the trailing twelve-month figure through Sep 2025 stood at $20.6 million (up 7.32% YoY), and the FY2025 full-year result was $20.6 million, up 7.32% from the prior year.
• Long-Term Deferred Tax for Q3 2025 stood at $20.6 million, up from $19.2 million in the prior quarter.
• Across five years, Long-Term Deferred Tax topped out at $20.6 million in Q3 2025 and bottomed at $8.9 million in Q3 2021.
• The 5-year median for Long-Term Deferred Tax is $15.4 million (2023), against an average of $15.2 million.
• The widest annual swing landed in 2021, when Long-Term Deferred Tax jumped 55.81%; it then advanced 7.32% in 2025.
• A 5-year view of Long-Term Deferred Tax shows it stood at $8.9 million in 2021, then soared by 35.9% to $12.1 million in 2022, then rose by 27.95% to $15.4 million in 2023, then advanced by 24.22% to $19.2 million in 2024, then increased by 7.32% to $20.6 million in 2025.
• The last three Long-Term Deferred Tax figures came in at $20.6 million (Q3 2025), $19.2 million (Q3 2024), and $15.4 million (Q3 2023), per Business Quant data.

Peer Comparison